Search EN menu en EIB GROUP CLIENT PORTAL
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

Signature(s)

Amount
€ 50,000,000
Countries
Sector(s)
Nigeria : € 50,000,000
Services : € 50,000,000
Signature date(s)
21/12/2025 : € 50,000,000
Link to source

Summary sheet

Release date
29 December 2025
Status
Reference
Signed | 21/12/2025
20250173
Project name
Promoter - financial intermediary
BANK OF INDUSTRY HEALTHCARE LOAN (HDX)
BANK OF INDUSTRY LTD
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 50 million
EUR 100 million
Location
Sector(s)
Description
Objectives

Support to healthcare manufacturing projects in Nigeria addressing unmet medical needs including research and development and the manufacturing of medicinal products such as pharmaceuticals, vaccines, medical devices, and nutritional products through a financing facility of €50 million loan to the Bank of Industry.

The principal objective of the project is to strengthen Nigeria's healthcare systems by investing in local manufacturing of medical devices and pharmaceuticals and medical research through a financial sector credit line under the Human Development Window mandate. The credit line is being put in place in parallel to a partial portfolio guarantee of up to €25 million. The financing package will be an important contributor to Nigeria's ambitions for self-sufficiency in managing its healthcare systems and supplying crucial medicines locally.

Additionality and Impact

The project aims to boost Nigeria's healthcare systems by leveraging a partnership with Bank of Industry to unlock financing for projects that fulfil an unmet medical need and support manufacturing and research and development (R&D) of medicinal products, devices, diagnostics and nutritional products.

The investment is delivered under the Human Development Accelerator (HDX) programme, an initiative backed by the European Commission and implemented in partnership with the Gates Foundation. It is part of the Global Gateway Health Package and aligned to the Team Europe Initiative for Manufacturing and Access to Vaccines (TEI MAV+).

The additionality of the financing is derived from the competitive offer, long tenor and grace period that will enable Bank of Industry to make long term patient investments in local healthcare projects. In addition, by working with Bank of Industry, EIB will be able to support local healthcare projects that require smaller investments and local currency, increasing the overall impact that EIB is having in the local healthcare sector.

Environmental aspects
Procurement

The final beneficiaries benefiting from EIB financing will be required to comply with the EIB Group's Environmental and Social Policy and the EIB Environmental and Social Standards.

The borrower and the sub-projects will be required to comply with the EIB's Guide to Procurement where applicable.

Under Global Europe NDICI guarantee

Under EFSD+ Guarantee

Milestone
Under appraisal
Approved
Signed
22 October 2025
21 December 2025
Link to source

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

Documents

Environmental and Social Data Sheet (ESDS) - BANK OF INDUSTRY HEALTHCARE LOAN (HDX)
Publication Date
6 Jan 2026
Document language
Main Topic
Lending
Document Number
247250296
Document Focus
Environmental Information
Project Number
20250173
Sector(s)
Countries
Publicly available
Download now

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Investigations Division. All reports will be treated as strictly confidential and handled in line with EIB investigation procedures and the EIB Group Anti-Fraud Policy.

Related publications